Elekta AB (SE:EKTAB): Interim Report May – July 2013/14  
9/3/2013 7:36:37 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Regulatory News:

Elekta (STO:EKTAB):

· Order bookings decreased 2* percent to SEK 2,027 M (2,252).

· Net sales increased 21* percent to SEK 1,912 M (1,695).

Help employers find you! Check out all the jobs and post your resume.